查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2173548

血液淨化設備市場：全球市場預測，2026-2032年

Blood Purification Equipment Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液淨化設備市場規模將達到 223.2 億美元，複合年成長率為 6.03%。

主要市場統計數據
基準年 2025 148.1億美元
預計年份：2026年 157.2億美元
預測年份 2032 223.2億美元
複合年成長率 (%) 6.03%

血液淨化裝置：概述

血液淨化設備有助於清除體內多餘的液體、代謝廢物、毒素、發炎介質或其他有害血液成分，既可體外進行，也可作為體內輔助手段。此領域涵蓋用於腎臟替代療法、血漿置換、血液灌流、吸附及相關臨床應用的系統及相關耗材。需求受腎臟疾病負擔、重症監護需求、治療可近性、臨床方案、保險報銷、感染控制標準以及訓練有素人員的可用性等因素的影響。

醫療服務正朝著全面且有效率的治療方向發展。

產業趨勢正朝著更整合的平台發展，這些平台整合了泵浦、監控、安全控制、一次性零件和資料連接等功能。醫院優先考慮的是護理的連續性、簡化的工作流程、更高的液體管理精度和更低的安裝複雜性。同時，強調分散式和居家照護的模式需要更緊湊、更易於使用的設備設計，以便進行遠端監控。供應鏈的韌性、永續的耗材以及嚴格的驗證也正成為採購過程中至關重要的考量。

利用人工智慧 (AI) 增強監測和臨床決策支持

人工智慧（AI）可透過異常檢測、最佳化治療參數、預測性警報、工作流程自動化以及對患者數據的長期分析，幫助血液淨化。其實際價值取決於來自感測器的高品質輸入資料、可靠的互通性、透明的檢驗以及臨床醫生的監督。醫院必須區分決策支援應用和自主控制系統，並在部署前解決網路安全、偏見、可解釋性、資料管治和監管課責。

區域洞察：醫療服務取得差異與通用臨床優先事項

在北美，重點通常放在先進的重症監護能力、門診和居家護理路徑、互通性以及基於價值的採購。在歐洲，臨床證據、病人安全、環境績效和統一的監管要求備受重視。在亞太地區，完善的醫療保健系統與快速成長的醫療服務需求並存，尤其是在日本、韓國和澳洲等市場。在拉丁美洲，鑑於基礎設施、報銷制度和進口依賴程度的差異，服務網路和可負擔性至關重要。在中東，對專科醫院和重症患者監護的投資正在穩步推進，海灣合作理事會（GCC）國家通常是技術應用的中心。非洲仍然存在很大的差異，為了實現永續的應用，獲得人力資源、可靠的公共基礎設施、維護系統、水質和耗材至關重要。

小組洞察：政策與經濟的協調一致是實施的關鍵

東協市場需要靈活的解決方案，以適應不同的監管架構、基礎設施條件和公私合營醫療模式。金磚國家面臨巨大的臨床需求，以及國內製造、採購和准入的各種優先事項。歐盟受益於協調一致的監管和品質框架，但實施和報銷仍取決於各國的具體情況。七國集團（G7）的醫療體系通常優先考慮實證醫學、網路安全、韌性以及與現有醫院基礎設施的整合。北約成員國可能還會考慮醫療服務的連續性、緊急準備和安全的醫療供應鏈。海灣合作理事會（GCC）國家通常強調先進的三級醫療、集中採購、人力資源發展以及快速採用專業技術。

國別洞察：地方體系決定實際執行情況

澳洲擁有高標準的臨床水準和地理分散的特點，因此需要遠端醫療服務覆蓋和支援。巴西和墨西哥在解決區域差異、公共部門採購以及獲得專科治療的機會不均等方面面臨挑戰。加拿大優先考慮省際醫療服務合作、農村地區醫療服務以及醫療專業人員的保障。中國和印度的臨床需求多種多樣，但醫院容量和本地化優先事項也存在顯著差異。法國、德國、義大利、西班牙和英國著重於基於監管的品管、醫院效率、報銷制度的規範以及與國家和地區醫療體系的整合。日本和韓國優先考慮準確性、可靠性、應對人口老化以及複雜的醫院工作流程。俄羅斯面臨基礎設施、供應和本地化方面的挑戰，這些挑戰可能會影響服務的連續性。在美國，複雜的報銷制度、重症監護能力、家庭護理、網路安全和臨床互通性等因素對遠距醫療的部署產生了重大影響。

領導者行動指南：建構具有韌性、以證據為基礎的平台

產業領導者應根據​​醫療環境和基礎設施細分其產品和服務，而不是追求單一的、統一的全球架構。他們應與護士和醫生合作，檢驗產品的可用性，加強培訓和現場支持，並設計即使在水、電、人員和通訊資源有限的情況下也能可靠運作的解決方案。投資重點應包括可互通的資料架構、具備人工干預能力的可解釋人工智慧、「網路安全設計」以及證明安全性、工作流程價值和以患者為中心的結果的證據。籌資策略應確保關鍵耗材的供應，根據需要認證多家供應商，並將生命週期成本、減少廢棄物、維護和當地監管要求納入考量。

調查方法：對臨床和系統因素進行結構化回顧

本執行摘要對血液淨化設備進行了結構化的定性評估，涵蓋技術、臨床環境、地區、國家醫療保健系統和醫療保健集團等多個方面。評估方法檢視了已記錄的臨床應用、治療流程、監管和報銷環境、基礎設施建設、人力資源需求、互通性、供應鏈狀況以及新興的數位化能力。評估結果以方向性見解而非數值化的市場預測呈現，其有效性應在檢驗投資或實施決策之前，根據當前的臨床指南、監管文件、採購記錄、同行評審文獻和醫療保健系統數據進行驗證。

結論：獲取途徑、可靠性和智慧是進步的關鍵。

血液淨化設備正從獨立的治療硬體發展成為互聯、監控和一體化的醫療照護系統。這項進步不僅取決於技術性能，還取決於可靠的耗材、訓練有素的醫護人員、公平的獲取途徑、網路安全、循證醫學證據的積累以及對當地醫療體系實際情況的適應。那些能夠將嚴謹的臨床實踐、穩健的運作和負責任的人工智慧相結合的領導者，將更有能力在各種環境下提升治療的連續性，並支持更安全、更有效率的醫療照護。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 血液淨化設備市場：依設備和組件分類

  • 按流程組裝
    • 血液透析機、血液透析過濾器和血液濾器
    • 腹膜透析裝置及卡式透析器
    • 血液和體液循環裝置
    • 等離子分離器
    • 吸附筒
  • 治療系統
    • 血液透析及血液透析濾過系統
    • 腹膜透析週期計
    • 連續性腎臟替代療法系統
    • 治療性血液分離系統
    • 血液灌注系統
  • 透析基礎設施
    • 水處理系統
    • 透析液製備與供應系統
  • 設備相關服務
  • 用於設備控制和連接的軟體

第8章 血液淨化設備市場：依淨化技術分類

  • 體外膜清洗
    • 擴散透析
    • 擴散和對流聯合淨化
    • 對流過濾
    • 膜血漿分離
  • 腹膜置換
  • 離心式血漿分離術
  • 外吸附淨化

第9章 血液淨化設備市場：依臨床應用分類

  • 腎臟替代療法和體液管理
    • 維持性腎臟替代療法
    • 急性腎衰竭的支持治療
  • 治療性血液成分管理
    • 血漿置換
    • 細胞分離與交換療法
  • 選擇性去除病理物質
    • 去除致病蛋白和抗體
    • 清除發炎介質
    • 清除藥物和毒素
    • 脂蛋白去除
    • 清除膽紅素和膽汁酸

第10章：血液淨化設備市場：依採購組織分類

  • 獨立透析服務提供者
  • 醫院和醫療系統
  • 血液中心及專業血液分離術服務機構

第11章：血液淨化設備市場：依醫療保健服務背景分類

  • 獨立門診治療機構
  • 醫院及急診機構
  • 居家醫療環境

第12章 血液淨化設備市場：依地區分類

  • 北美洲
  • 亞太地區
  • 歐洲
  • 拉丁美洲
  • 中東
  • 非洲

第13章 血液淨化設備市場：依組別分類

  • NATO
  • G7
  • EU
  • BRICS
  • ASEAN
  • GCC

第14章 血液淨化設備市場：依國家分類

  • 美國
  • 中國
  • 日本
  • 德國
  • 法國
  • 英國
  • 韓國
  • 義大利
  • 印度
  • 加拿大
  • 巴西
  • 西班牙
  • 俄羅斯
  • 澳洲
  • 墨西哥

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Fresenius Medical Care AG
  • Vantive
  • Nipro Corporation
  • Asahi Kasei Medical Co., Ltd.
  • Toray Industries, Inc.
  • Nikkiso Co., Ltd.
  • Jafron Biomedical Co., Ltd.
  • Terumo Blood and Cell Technologies, Inc.
  • CytoSorbents Corporation
  • Outset Medical, Inc.
  • SWS Hemodialysis Care Co., Ltd.
  • Bain Medical Equipment（Guangzhou）Co., Ltd.
  • Medica SpA
  • Allmed Medical Care Holdings Limited
  • Kaneka Corporation
  • JIMRO Co., Ltd.
  • INFOMED SA

第17章 主要專家

Product Code: MRR-562C14C35CA6

The Blood Purification Equipment Market is projected to grow by USD 22.32 billion at a CAGR of 6.03% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.81 billion
Estimated Year [2026] USD 15.72 billion
Forecast Year [2032] USD 22.32 billion
CAGR (%) 6.03%

Blood Purification Equipment: Executive Overview

Blood purification equipment supports the extracorporeal or extracorporeal-assisted removal of excess fluid, metabolic waste, toxins, inflammatory mediators, or other unwanted blood constituents. The field includes systems and associated consumables used in renal replacement therapy, plasma exchange, hemoperfusion, adsorption, and related clinical applications. Demand is shaped by the burden of kidney disease, critical-care requirements, treatment access, clinical protocols, reimbursement, infection-control standards, and the availability of trained personnel.

Care Delivery Is Shifting Toward Integrated, Efficient Treatment

The landscape is moving toward more integrated platforms that combine pumps, monitoring, safety controls, disposables, and data connectivity. Hospitals are emphasizing treatment continuity, simplified workflows, fluid-management precision, and reduced setup complexity. At the same time, decentralized and home-oriented care models are encouraging equipment designs that are more compact, user-friendly, and suitable for remote supervision. Supply-chain resilience, sustainable consumables, and rigorous validation are also becoming central procurement considerations.

Artificial Intelligence Strengthens Monitoring and Clinical Decision Support

Artificial intelligence can contribute to blood purification through anomaly detection, treatment-parameter optimization, predictive alerts, workflow automation, and analysis of longitudinal patient data. Its practical value depends on high-quality inputs from sensors, reliable interoperability, transparent validation, and clinician oversight. Hospitals should distinguish between decision-support applications and autonomous control, while addressing cybersecurity, bias, explainability, data governance, and regulatory accountability before deployment.

Regional Insights: Uneven Access Meets Common Clinical Priorities

North America generally emphasizes advanced intensive-care capabilities, outpatient and home-treatment pathways, interoperability, and value-based procurement. Europe places strong weight on clinical evidence, patient safety, environmental performance, and harmonized regulatory requirements. Asia-Pacific combines sophisticated health systems in markets such as Japan, South Korea, and Australia with rapidly expanding access needs across diverse care settings. Latin America faces variation in infrastructure, reimbursement, and import dependence, making service networks and affordability important. The Middle East is investing in specialized hospitals and high-acuity care, while the GCC often serves as a technology-adoption hub. Africa remains highly diverse, with workforce capacity, reliable utilities, maintenance, water quality, and consumable availability central to sustainable deployment.

Group Insights: Policy and Economic Alignment Shape Adoption

ASEAN markets require adaptable solutions that accommodate different regulatory systems, infrastructure conditions, and public-private care models. BRICS economies combine substantial clinical needs with varied domestic manufacturing, procurement, and access priorities. The European Union benefits from coordinated regulatory and quality frameworks, although implementation and reimbursement remain nationally influenced. G7 health systems typically prioritize evidence, cybersecurity, resilience, and integration with established hospital infrastructure. NATO members may additionally consider continuity of care, emergency preparedness, and secure medical supply chains. GCC countries commonly emphasize advanced tertiary care, centralized procurement, workforce development, and rapid deployment of specialized technologies.

Country Insights: Local Systems Determine Practical Deployment

Australia combines strong clinical standards with geographic dispersion, making service coverage and remote-care support relevant. Brazil and Mexico must navigate regional inequality, public-sector procurement, and uneven access to specialized treatment. Canada emphasizes coordinated provincial delivery, rural access, and workforce availability. China and India present broad clinical needs alongside significant variation in hospital capability and localization priorities. France, Germany, Italy, Spain, and the United Kingdom focus on regulated quality, hospital efficiency, reimbursement discipline, and integration with national or regional health systems. Japan and South Korea emphasize precision, reliability, aging-population care, and advanced hospital workflows. Russia faces infrastructure, supply, and localization considerations that can affect continuity. In the United States, complex reimbursement, intensive-care capacity, home treatment, cybersecurity, and clinical interoperability strongly influence adoption.

Actions for Leaders: Build Resilient, Evidence-Based Platforms

Industry leaders should segment offerings by care setting and infrastructure rather than pursue a single global configuration. They should validate usability with nurses and physicians, strengthen training and field service, and design for dependable operation where water, power, staffing, or connectivity may be constrained. Investment priorities should include interoperable data architecture, explainable AI with human override, cybersecurity-by-design, and evidence that demonstrates safety, workflow value, and patient-centered outcomes. Procurement strategies should secure critical consumables, qualify multiple suppliers where appropriate, and incorporate lifecycle cost, waste reduction, maintenance, and local regulatory requirements.

Research Methodology: Structured Review of Clinical and System Drivers

This executive summary uses a structured, qualitative assessment of blood purification equipment across technologies, care settings, regions, country systems, and institutional groupings. The approach considers documented clinical applications, treatment workflows, regulatory and reimbursement environments, infrastructure readiness, workforce requirements, interoperability, supply-chain conditions, and emerging digital capabilities. Findings are framed as directional insights rather than numerical market estimates, and claims should be validated against current clinical guidelines, regulatory publications, procurement records, peer-reviewed literature, and health-system data before investment or implementation decisions.

Conclusion: Access, Reliability, and Intelligence Will Define Progress

Blood purification equipment is evolving from standalone treatment hardware toward connected, monitored, and workflow-integrated care systems. Progress will depend not only on technical performance, but also on dependable consumables, trained staff, equitable access, cybersecurity, evidence generation, and fit with local health-system realities. Leaders that combine clinical rigor with resilient operations and responsible artificial intelligence will be better positioned to improve treatment continuity and support safer, more efficient care across diverse settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
      • 4.3.1.1. Persistent chronic and acute kidney-treatment need
      • 4.3.1.2. Recurring procedure-component consumption
      • 4.3.1.3. Diversification of care settings and purification modalities
      • 4.3.1.4. Digitalization of equipment and lifecycle support
    • 4.3.2. Key Restraints
      • 4.3.2.1. Affordability and coverage gaps constrain conversion of clinical need
      • 4.3.2.2. Infrastructure and workforce dependencies restrict deployment
      • 4.3.2.3. Regulatory and lifecycle obligations raise commercialization costs
    • 4.3.3. Key Opportunities
      • 4.3.3.1. Integrated home-treatment ecosystems
      • 4.3.3.2. Specialty and multimodality purification platforms
      • 4.3.3.3. Access-oriented localization in expanding markets
      • 4.3.3.4. Digital lifecycle and equipment-linked services
    • 4.3.4. Key Challenges
      • 4.3.4.1. Quality, compatibility, and treatment-continuity execution
      • 4.3.4.2. Cybersecurity and interoperability management
      • 4.3.4.3. Service execution across diverse emerging markets
      • 4.3.4.4. Balancing platform attachment with buyer switching concerns
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Blood Purification Equipment Market, by Equipment and Components

  • 7.1. Introduction
  • 7.2. Procedure-Specific Components
    • 7.2.1. Hemodialyzers, Hemodiafilters, and Hemofilters
    • 7.2.2. Peritoneal Dialysis Sets and Cassettes
    • 7.2.3. Blood and Fluid Circuit Sets
    • 7.2.4. Plasma Separators
    • 7.2.5. Adsorption Cartridges
  • 7.3. Treatment Systems
    • 7.3.1. Hemodialysis and Hemodiafiltration Systems
    • 7.3.2. Peritoneal Dialysis Cyclers
    • 7.3.3. Continuous Kidney-Replacement Systems
    • 7.3.4. Therapeutic Apheresis Systems
    • 7.3.5. Hemoperfusion Systems
  • 7.4. Dialysis Infrastructure
    • 7.4.1. Water-Treatment Systems
    • 7.4.2. Dialysate Preparation and Delivery Systems
  • 7.5. Equipment-Linked Services
  • 7.6. Equipment Control and Connectivity Software

8. Blood Purification Equipment Market, by Purification Technology

  • 8.1. Introduction
  • 8.2. Extracorporeal Membrane-Based Purification
    • 8.2.1. Diffusive Dialysis
    • 8.2.2. Combined Diffusive-Convective Purification
    • 8.2.3. Convective Filtration
    • 8.2.4. Membrane Plasma Separation
  • 8.3. Peritoneal Membrane Exchange
  • 8.4. Centrifugal Apheresis
  • 8.5. Extracorporeal Adsorptive Purification

9. Blood Purification Equipment Market, by Clinical Application

  • 9.1. Introduction
  • 9.2. Kidney Replacement and Fluid Management
    • 9.2.1. Maintenance Kidney Replacement
    • 9.2.2. Acute Kidney Support
  • 9.3. Therapeutic Blood-Component Management
    • 9.3.1. Plasma Exchange
    • 9.3.2. Cellular Apheresis and Exchange
  • 9.4. Selective Pathologic Substance Removal
    • 9.4.1. Pathogenic Protein and Antibody Removal
    • 9.4.2. Inflammatory Mediator Removal
    • 9.4.3. Drug and Toxin Removal
    • 9.4.4. Lipoprotein Removal
    • 9.4.5. Bilirubin and Bile-Acid Removal

10. Blood Purification Equipment Market, by Purchasing Organization

  • 10.1. Introduction
  • 10.2. Freestanding Dialysis Providers
  • 10.3. Hospitals and Health Systems
  • 10.4. Blood Centers and Specialty Apheresis Providers

11. Blood Purification Equipment Market, by Care Delivery Setting

  • 11.1. Introduction
  • 11.2. Freestanding Outpatient Treatment Facilities
  • 11.3. Hospitals and Acute-Care Facilities
  • 11.4. Home Healthcare Environments

12. Blood Purification Equipment Market, by Region

  • 12.1. Introduction
  • 12.2. North America
  • 12.3. Asia-Pacific
  • 12.4. Europe
  • 12.5. Latin America
  • 12.6. Middle East
  • 12.7. Africa

13. Blood Purification Equipment Market, by Group

  • 13.1. Introduction
  • 13.2. NATO
  • 13.3. G7
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. ASEAN
  • 13.7. GCC

14. Blood Purification Equipment Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. China
  • 14.4. Japan
  • 14.5. Germany
  • 14.6. France
  • 14.7. United Kingdom
  • 14.8. South Korea
  • 14.9. Italy
  • 14.10. India
  • 14.11. Canada
  • 14.12. Brazil
  • 14.13. Spain
  • 14.14. Russia
  • 14.15. Australia
  • 14.16. Mexico

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Fresenius Medical Care AG
  • 16.2. Vantive
  • 16.3. Nipro Corporation
  • 16.4. Asahi Kasei Medical Co., Ltd.
  • 16.5. Toray Industries, Inc.
  • 16.6. Nikkiso Co., Ltd.
  • 16.7. Jafron Biomedical Co., Ltd.
  • 16.8. Terumo Blood and Cell Technologies, Inc.
  • 16.9. CytoSorbents Corporation
  • 16.10. Outset Medical, Inc.
  • 16.11. SWS Hemodialysis Care Co., Ltd.
  • 16.12. Bain Medical Equipment (Guangzhou) Co., Ltd.
  • 16.13. Medica S.p.A.
  • 16.14. Allmed Medical Care Holdings Limited
  • 16.15. Kaneka Corporation
  • 16.16. JIMRO Co., Ltd.
  • 16.17. INFOMED SA

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Blood Purification Equipment Market, Years Considered for the Study
  • FIGURE 2. Global Blood Purification Equipment Market, Research Design
  • FIGURE 3. Global Blood Purification Equipment Market, Research Framework
  • FIGURE 4. Global Blood Purification Equipment Market, Data Triangulation
  • FIGURE 5. Global Blood Purification Equipment Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Blood Purification Equipment Market Size, by Equipment and Components, 2025 vs 2032 (%)
  • FIGURE 7. Global Blood Purification Equipment Market Size, by Equipment and Components, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Blood Purification Equipment Market Size, by Purification Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Blood Purification Equipment Market Size, by Purification Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Blood Purification Equipment Market Size, by Clinical Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Blood Purification Equipment Market Size, by Clinical Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Blood Purification Equipment Market Size, by Purchasing Organization, 2025 vs 2032 (%)
  • FIGURE 13. Global Blood Purification Equipment Market Size, by Purchasing Organization, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Blood Purification Equipment Market Size, by Care Delivery Setting, 2025 vs 2032 (%)
  • FIGURE 15. Global Blood Purification Equipment Market Size, by Care Delivery Setting, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Blood Purification Equipment Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Blood Purification Equipment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Blood Purification Equipment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Blood Purification Equipment Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Blood Purification Equipment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Blood Purification Equipment Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Blood Purification Equipment Market Segmentation & Coverage
  • TABLE 2. Global Blood Purification Equipment Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 4. Global Procedure-Specific Components Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Procedure-Specific Components Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Procedure-Specific Components Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Hemodialyzers, Hemodiafilters, and Hemofilters Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Hemodialyzers, Hemodiafilters, and Hemofilters Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Hemodialyzers, Hemodiafilters, and Hemofilters Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Peritoneal Dialysis Sets and Cassettes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Peritoneal Dialysis Sets and Cassettes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Peritoneal Dialysis Sets and Cassettes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Blood and Fluid Circuit Sets Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Blood and Fluid Circuit Sets Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Blood and Fluid Circuit Sets Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Plasma Separators Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Plasma Separators Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Plasma Separators Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Adsorption Cartridges Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Adsorption Cartridges Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Adsorption Cartridges Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Treatment Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Treatment Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Treatment Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Hemodialysis and Hemodiafiltration Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Hemodialysis and Hemodiafiltration Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Hemodialysis and Hemodiafiltration Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Peritoneal Dialysis Cyclers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Peritoneal Dialysis Cyclers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Peritoneal Dialysis Cyclers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Continuous Kidney-Replacement Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Continuous Kidney-Replacement Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Continuous Kidney-Replacement Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Therapeutic Apheresis Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Therapeutic Apheresis Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Therapeutic Apheresis Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Hemoperfusion Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Hemoperfusion Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Hemoperfusion Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Dialysis Infrastructure Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Dialysis Infrastructure Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Dialysis Infrastructure Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Water-Treatment Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Water-Treatment Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Water-Treatment Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Dialysate Preparation and Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Dialysate Preparation and Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Dialysate Preparation and Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Equipment-Linked Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Equipment-Linked Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Equipment-Linked Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Equipment Control and Connectivity Software Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 53. Global Equipment Control and Connectivity Software Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 54. Global Equipment Control and Connectivity Software Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 55. Global Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 56. Global Extracorporeal Membrane-Based Purification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Extracorporeal Membrane-Based Purification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Extracorporeal Membrane-Based Purification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Diffusive Dialysis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Diffusive Dialysis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Diffusive Dialysis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Combined Diffusive-Convective Purification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Combined Diffusive-Convective Purification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Combined Diffusive-Convective Purification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Convective Filtration Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Convective Filtration Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Convective Filtration Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Membrane Plasma Separation Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Membrane Plasma Separation Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Membrane Plasma Separation Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Peritoneal Membrane Exchange Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Peritoneal Membrane Exchange Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Peritoneal Membrane Exchange Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Centrifugal Apheresis Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 75. Global Centrifugal Apheresis Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 76. Global Centrifugal Apheresis Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 77. Global Extracorporeal Adsorptive Purification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Global Extracorporeal Adsorptive Purification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. Global Extracorporeal Adsorptive Purification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 80. Global Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 81. Global Kidney Replacement and Fluid Management Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Kidney Replacement and Fluid Management Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Kidney Replacement and Fluid Management Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Maintenance Kidney Replacement Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Maintenance Kidney Replacement Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Maintenance Kidney Replacement Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Acute Kidney Support Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global Acute Kidney Support Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global Acute Kidney Support Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Therapeutic Blood-Component Management Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global Therapeutic Blood-Component Management Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global Therapeutic Blood-Component Management Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Plasma Exchange Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Plasma Exchange Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Plasma Exchange Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global Cellular Apheresis and Exchange Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Global Cellular Apheresis and Exchange Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. Global Cellular Apheresis and Exchange Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. Global Selective Pathologic Substance Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Selective Pathologic Substance Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Selective Pathologic Substance Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global Pathogenic Protein and Antibody Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Pathogenic Protein and Antibody Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Pathogenic Protein and Antibody Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Inflammatory Mediator Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Inflammatory Mediator Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Inflammatory Mediator Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Drug and Toxin Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Drug and Toxin Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Drug and Toxin Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Lipoprotein Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 112. Global Lipoprotein Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 113. Global Lipoprotein Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 114. Global Bilirubin and Bile-Acid Removal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 115. Global Bilirubin and Bile-Acid Removal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 116. Global Bilirubin and Bile-Acid Removal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 117. Global Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 118. Global Freestanding Dialysis Providers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. Global Freestanding Dialysis Providers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. Global Freestanding Dialysis Providers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 121. Global Hospitals and Health Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 122. Global Hospitals and Health Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 123. Global Hospitals and Health Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 124. Global Blood Centers and Specialty Apheresis Providers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Global Blood Centers and Specialty Apheresis Providers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. Global Blood Centers and Specialty Apheresis Providers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 127. Global Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 128. Global Freestanding Outpatient Treatment Facilities Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 129. Global Freestanding Outpatient Treatment Facilities Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. Global Freestanding Outpatient Treatment Facilities Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 131. Global Hospitals and Acute-Care Facilities Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 132. Global Hospitals and Acute-Care Facilities Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 133. Global Hospitals and Acute-Care Facilities Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 134. Global Home Healthcare Environments Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Global Home Healthcare Environments Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. Global Home Healthcare Environments Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. Global Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 138. North America Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 139. North America Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 140. North America Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 141. North America Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 142. North America Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 143. North America Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 144. North America Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 145. North America Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 146. North America Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 147. North America Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 148. North America Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 149. North America Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 150. North America Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 151. Asia-Pacific Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 152. Asia-Pacific Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 153. Asia-Pacific Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 154. Asia-Pacific Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 155. Asia-Pacific Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 156. Asia-Pacific Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 157. Asia-Pacific Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 158. Asia-Pacific Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 159. Asia-Pacific Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 160. Asia-Pacific Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 161. Asia-Pacific Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 162. Asia-Pacific Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 163. Asia-Pacific Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 164. Europe Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 165. Europe Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 166. Europe Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 167. Europe Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 168. Europe Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 169. Europe Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 170. Europe Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 171. Europe Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 172. Europe Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 173. Europe Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 174. Europe Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 175. Europe Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 176. Europe Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 177. Latin America Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 178. Latin America Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 179. Latin America Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 180. Latin America Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 181. Latin America Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 182. Latin America Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 183. Latin America Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 184. Latin America Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 185. Latin America Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 186. Latin America Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 187. Latin America Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 188. Latin America Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 189. Latin America Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 190. Middle East Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 191. Middle East Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 192. Middle East Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 193. Middle East Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 194. Middle East Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 195. Middle East Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 196. Middle East Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 197. Middle East Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 198. Middle East Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 199. Middle East Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 200. Middle East Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 201. Middle East Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 202. Middle East Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 203. Africa Blood Purification Equipment Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 204. Africa Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 205. Africa Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 206. Africa Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 207. Africa Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 208. Africa Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 209. Africa Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 210. Africa Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 211. Africa Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 212. Africa Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 213. Africa Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 214. Africa Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 215. Africa Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 216. Global Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 217. NATO Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 218. NATO Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 219. NATO Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 220. NATO Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 221. NATO Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 222. NATO Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 223. NATO Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 224. NATO Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 225. NATO Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 226. NATO Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 227. NATO Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 228. NATO Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 229. NATO Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 230. G7 Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 231. G7 Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 232. G7 Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 233. G7 Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 234. G7 Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 235. G7 Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 236. G7 Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 237. G7 Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 238. G7 Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 239. G7 Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 240. G7 Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 241. G7 Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 242. G7 Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 243. European Union Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 244. European Union Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 245. European Union Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 246. European Union Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 247. European Union Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 248. European Union Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 249. European Union Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 250. European Union Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 251. European Union Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 252. European Union Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 253. European Union Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 254. European Union Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 255. European Union Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 256. BRICS Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 257. BRICS Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 258. BRICS Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 259. BRICS Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 260. BRICS Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 261. BRICS Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 262. BRICS Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 263. BRICS Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 264. BRICS Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 265. BRICS Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 266. BRICS Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 267. BRICS Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 268. BRICS Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 269. ASEAN Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 270. ASEAN Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 271. ASEAN Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 272. ASEAN Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 273. ASEAN Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 274. ASEAN Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 275. ASEAN Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 276. ASEAN Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 277. ASEAN Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 278. ASEAN Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 279. ASEAN Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 280. ASEAN Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 281. ASEAN Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 282. GCC Blood Purification Equipment Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 283. GCC Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 284. GCC Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 285. GCC Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 286. GCC Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 287. GCC Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 288. GCC Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 289. GCC Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 290. GCC Blood Purification Equipment Market Size, by Kidney Replacement and Fluid Management, 2017-2032 (USD Million)
  • TABLE 291. GCC Blood Purification Equipment Market Size, by Therapeutic Blood-Component Management, 2017-2032 (USD Million)
  • TABLE 292. GCC Blood Purification Equipment Market Size, by Selective Pathologic Substance Removal, 2017-2032 (USD Million)
  • TABLE 293. GCC Blood Purification Equipment Market Size, by Purchasing Organization, 2017-2032 (USD Million)
  • TABLE 294. GCC Blood Purification Equipment Market Size, by Care Delivery Setting, 2017-2032 (USD Million)
  • TABLE 295. Global Blood Purification Equipment Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 296. United States Blood Purification Equipment Market Size, 2017-2032 (USD Million)
  • TABLE 297. United States Blood Purification Equipment Market Size, by Equipment and Components, 2017-2032 (USD Million)
  • TABLE 298. United States Blood Purification Equipment Market Size, by Procedure-Specific Components, 2017-2032 (USD Million)
  • TABLE 299. United States Blood Purification Equipment Market Size, by Treatment Systems, 2017-2032 (USD Million)
  • TABLE 300. United States Blood Purification Equipment Market Size, by Dialysis Infrastructure, 2017-2032 (USD Million)
  • TABLE 301. United States Blood Purification Equipment Market Size, by Purification Technology, 2017-2032 (USD Million)
  • TABLE 302. United States Blood Purification Equipment Market Size, by Extracorporeal Membrane-Based Purification, 2017-2032 (USD Million)
  • TABLE 303. United States Blood Purification Equipment Market Size, by Clinical Application, 2017-2032 (USD Million)
  • TABLE 304. United States Blood Purification Equipment Market Size, by Kidney Repla